EUVIMEDEUVIMED entdecken
Crossref

Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke

Lan Gao iD, Leonid Churilov, Hannah Johns, Deep Pujara, Ameer E Hassan, Michael Abraham, Santiago Ortega-Gutierrez, Muhammad Shazam Hussain, Michael Chen, Spiros Blackburn, Clark W Sitton, Florentina M E Pinckaers und 9 weitere

Annals of Neurology · 2025

DOI: 10.1002/ana.27119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Lan Gao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Faculty of Health, Deakin University, Burwood,…. Hauptthemen laut MEDLINE: Thrombectomy, Cost-Benefit Analysis, Ischemic Stroke, Endovascular Procedures. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Whereas highly cost‐effective and cost‐saving for patients with small infarcts, whether endovascular thrombectomy (EVT) remains cost‐effective in patients with extensive ischemic injury is uncertain.

Methods

We conducted a model‐based cost‐effectiveness analysis from the United States, Australian, and Spanish societal perspectives, using a 7‐state Markov model, with each state defined by the modified Rankin Scale (mRS) score. Initial probabilities at 3 months were derived from the SELECT2 trial. All other model inputs, including transition probabilities, health care and non‐health care costs, and utility weights, were sourced from published literature and government websites. Our analysis included extensive sensitivity and subgroup analyses.

Results

EVT in patients with large ischemic stroke improved health outcomes and was associated with lower costs from a societal viewpoint. EVT was cost‐effective with a mean between‐group difference of 1.24 quality‐adjusted life years (QALYs), and a cost‐saving of $23,409 in the United States, $10,691 in Australia, and $30,036 in Spain, in addition to uncosted benefits in productivity for patients and carers. Subgroup analyses were directionally consistent with the overall population, notably with preserved cost‐effectiveness in older patients (≥ 70 years) and those with more severe strokes (National Institutes of Health Stroke Scale [NIHSS] ≥ 20). Sensitivity analyses were largely consistent with the base‐case results.

Interpretation

EVT demonstrated cost‐effectiveness in patients with large core across different settings in the United States, Australia, and Spain, including older patients and those with more severe strokes. These results further support adaptation of systems of care to accommodate the expansion of thrombectomy eligibility to patients with large cores and maximize EVT benefits. ANN NEUROL 2025;97:222–231

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombectomyCost-Benefit AnalysisIschemic StrokeEndovascular ProceduresHumansAustraliaUnited StatesQuality-Adjusted Life YearsAgedMaleFemaleSpainMarkov ChainsMiddle Aged

Autor:innen und Institutionen

  • Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Faculty of Health, Deakin University, Burwood, Australia.
  • Department of Medicine and Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
  • Department of Neurology, University Hospital Cleveland Medical Center - Case Western Reserve University, Cleveland, OH.
  • Department of Neuroscience, Valley Baptist Medical Center, Harlingen, TX.
  • Department of Neurology, University of Kansas Medical Center, Kansas City, KS.
  • Department of Neurosurgery and Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA.

ORCID-Profile: Lan Gao, Georgios Tsivgoulis, Scott Kasner, Bruce C Campbell, Amrou Sarraj

Zitieren

APA

Gao, L., Churilov, L., Johns, H., Pujara, D., Hassan, A. E., Abraham, M., Ortega-Gutierrez, S., Hussain, M. S., Chen, M., Blackburn, S., Sitton, C. W., Pinckaers, F. M. E., van Zwam, W. H., Tsivgoulis, G., Hill, M. D., Grotta, J. C., Kasner, S., Ribo, M., Campbell, B. C., …, & For SELECT2 investigators (2025). Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke. Annals of Neurology. https://doi.org/10.1002/ana.27119

Vancouver

Gao L, Churilov L, Johns H, Pujara D, Hassan AE, Abraham M, et al. Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke. Annals of Neurology. 2025. doi:10.1002/ana.27119

BibTeX
@article{Gao2025,
  author = {Gao, Lan and Churilov, Leonid and Johns, Hannah and Pujara, Deep and Hassan, Ameer E and Abraham, Michael and Ortega-Gutierrez, Santiago and Hussain, Muhammad Shazam and Chen, Michael and Blackburn, Spiros and Sitton, Clark W and Pinckaers, Florentina M E and van Zwam, Wim H and Tsivgoulis, Georgios and Hill, Michael D and Grotta, James C and Kasner, Scott and Ribo, Marc and Campbell, Bruce C and Sarraj, Amrou and For SELECT2 investigators, For SELECT2 investigators},
  title = {Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27119}
}
Kostenlos starten →